Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential
Non-alcoholic fatty liver disease (NAFLD) is a common clinical disease, and its pathogenesis is closely linked to oxidative stress and gut microbiota dysbiosis. Recently accumulating evidence indicates that the thioredoxin and glutaredoxin systems, the two thiol-redox dependent antioxidant systems,...
Main Authors: | Minghui Zhu, Omer M. A. Dagah, Billton Bryson Silaa, Jun Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/12/9/1680 |
Similar Items
-
Fecal Microbiota Transplantation in NAFLD Treatment
by: Ludovico Abenavoli, et al.
Published: (2022-10-01) -
Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease
by: Tian Liang, et al.
Published: (2022-11-01) -
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01) -
Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review
by: Yi-Hsun Chen, et al.
Published: (2020-08-01) -
The interplay between oral microbiota, gut microbiota and systematic diseases
by: Xiujun Tan, et al.
Published: (2023-12-01)